I prefer to track pricing using quarterly reports. What fast markets show is tiny spot volume pricing. For example that spodumene price is based on Pilbaras bmx auction which is <0.25% of all spodumene sold at doubles pilbaras average price in the sept qtr. I suspect it is similar for carb and hydroxide.
The spot market pricing moves much quicker in both directions. It works well while prices are rising but not so well when prices are falling.
It spooks investors to see prices coming off while pricing for majority of traded volumes pricing continues to climb.
In any case it is an indicator and should be provided with context. I question the merit of reporting such pricing without showing the respective volumes alongside to provide a more transparent picture of market dynamics.
Aimo
AKE Price at posting:
$13.17 Sentiment: None Disclosure: Held
